Four notes:
1. Terms of the deal weren’t disclosed. The transaction will be finalized upon completion of closing conditions.
2. Flower Orthopedics develops sterile-packaged foot and ankle implants, allografts and diabetic wound care products for orthopedic surgeons and podiatrists.
3. In December, Conventus acquired all assets of Surgical Frontiers’ IntraFuse, expanding into the lower extremity orthopedics market.
4. On the heels of its latest deal, Conventus plans to continue pursuing technologies clinically relevant to hospitals, ASCs and surgeons.
More articles on spine and orthopedics:
AAOS, OREF partner to drive funding for biologic, total joint replacement research
NuVasive Q1 net income drops 43.6%, shares down 27% since start of year
Dr. Charles Branch Jr.: Imaging, patient engagement big opportunities in spine post-pandemic
